Summary: New research from the University of Cambridge reveals a specialized metabolic pathway in neurons and glial cells that controls mTORC1 signaling through leucine-derived acetyl-coenzyme A (AcCoA) and p300-mediated acetylation of Raptor. This neuronal-specific sensor diverges from canonical amino-acid sensing models and provides promising upstream targets to prevent chronic mTORC1 hyperactivation, restore autophagy, and address toxic protein accumulation in neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Neurons are long-lived and cannot reduce damaged protein concentrations by dividing, so they rely on precise nutrient sensing, protein quality control, and autophagy to maintain proteostasis. The newly described AcCoA–p300–Raptor axis offers a refined explanation for how metabolic flux controls neuronal mTORC1 and how its dysregulation contributes to neurodegeneration.
Key Facts
- Longevity demands strict cleanup: Because neurons persist for decades and do not divide, they depend on tightly regulated systems—particularly autophagy—to clear damaged proteins and maintain function.
- Limitations of HEK293-based models: Much of mTORC1 biology was defined in HEK293 and other non-neuronal cell lines. Neuronal nutrient sensing shows important differences from those canonical models.
- AcCoA activates p300 to control mTORC1: In neurons and glia, leucine metabolism produces AcCoA, which activates the acetyltransferase p300. p300 acetylates Raptor, a core mTORC1 subunit, promoting mTORC1 activation and suppressing autophagy.
- mTORC1 hyperactivation drives proteotoxicity: Chronic mTORC1 overactivity impairs autophagy and is implicated in pathological protein accumulation across Alzheimer’s, Parkinson’s, Huntington’s disease, and ALS.
- Metabolic and inflammatory convergence: Distinct inputs—excess AcCoA and inflammatory signaling via receptors such as CCR5—can both converge on neuronal mTORC1, producing compounded autophagy failure.
- Upstream interventions are promising: Instead of broadly inhibiting mTORC1, targeting upstream metabolic steps (AcCoA production), p300 activity, or inflammatory-metabolic crosstalk may offer safer, more selective therapeutic strategies.
Source: Science Exploration Press
Researchers from the University of Cambridge describe how neurons and glia use a distinct metabolic mechanism to sense nutrients and regulate mTORC1, opening potential therapeutic avenues for neurodegenerative disorders.
Neurons require lifelong proteostasis and stress resilience. Unlike dividing cells that can dilute damaged proteins, neurons depend on regulated autophagy and tightly tuned nutrient-sensing pathways to prevent toxic accumulation. The review led by Prof. David C. Rubinsztein synthesizes evidence that leucine-derived AcCoA plays a central role in neuronal mTORC1 regulation by activating p300 and promoting Raptor acetylation, a mechanism less emphasized in studies using non-neuronal cell lines.
The review evaluates how AcCoA links amino-acid metabolism to mTORC1 activity and highlights disease-related consequences. Persistent activation of mTORC1 disrupts normal autophagic clearance, contributing to hallmark pathologies: tau and amyloid-β accumulation in Alzheimer’s disease, α-synuclein aggregation and mitophagy defects in Parkinson’s, impaired clearance of mutant huntingtin in Huntington’s disease, and proteostasis failure in ALS.
Rather than attempting direct, systemic mTORC1 inhibition—which risks interfering with essential growth and metabolic functions—the authors emphasize therapeutic approaches that modulate upstream metabolism or the acetylation machinery. Examples include limiting local AcCoA synthesis, inhibiting p300 acetyltransferase activity in affected neural circuits, or blocking inflammatory signals that potentiate mTORC1 activation.
The review also documents how metabolic and inflammatory pathways intersect at mTORC1. Elevated AcCoA and CCR5-mediated inflammatory signaling represent distinct triggers that both promote mTORC1 hyperactivation and autophagy failure, suggesting combined or targeted interventions may be required in disease contexts.
“Neuronal nutrient sensing displays specific differences from the patterns observed in HEK293 cells,” the authors write. “Recognizing these neuron-specific control mechanisms reveals upstream therapeutic opportunities that could restore autophagy without broadly suppressing mTORC1 across the whole body.”
The review highlights several translational directions under investigation: metabolic modulators to reduce AcCoA availability in neurons, selective inhibitors of p300-mediated acetylation, and approaches to interrupt inflammatory-metabolic crosstalk that drives pathological mTORC1 activity.
Key Questions Answered:
A: Neurons are designed to last a lifetime and lack the ability to divide. Other cells can dilute toxic proteins by splitting; neurons cannot. Therefore, neurons rely entirely on internal clearance systems—especially autophagy—to remove damaged proteins and maintain cellular health.
A: AcCoA acts as a metabolic signal that stimulates p300, an acetyltransferase. p300 acetylates Raptor, a core component of mTORC1, pushing mTORC1 into a chronically active state. Persistent mTORC1 activation biases the cell toward growth and protein synthesis while suppressing autophagy, preventing the removal of toxic proteins.
A: mTORC1 governs fundamental processes across many tissues. Direct systemic inhibition risks serious side effects by disrupting necessary growth and metabolic functions. Targeting upstream nodes—such as AcCoA production or p300 activity—offers a more precise strategy to normalize neuronal signaling without compromising vital mTORC1-dependent processes elsewhere.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by editorial staff.
About this neuroscience research news
Author: Lijun Jin
Source: Science Exploration Press
Contact: Lijun Jin – Science Exploration Press
Image: The image is credited to Neuroscience News
Original Research: Open access. “Nutrient-sensing and mTORC1 regulation in neuronal homeostasis: from metabolic signaling to neurodegeneration” by Sung Min Son, Weining Li, and David C. Rubinsztein. EXO – Beyond the Cell. DOI: 10.70401/EXO.2026.0009
Abstract
Nutrient-sensing and mTORC1 regulation in neuronal homeostasis: from metabolic signaling to neurodegeneration
Neurons require precise nutrient-sensing systems to maintain proteostasis and resilience throughout life. Mechanistic target of rapamycin complex 1 (mTORC1) acts as a central hub that integrates amino acid levels, growth factor input, and cellular energy state to coordinate protein synthesis, autophagy, and neuronal survival. Neuronal mTORC1 regulation is uniquely adapted to neuronal metabolism, subcellular compartmentalisation, and long-term homeostatic demands.
Beyond classical PI3K–Akt and AMPK signaling, accumulating evidence identifies metabolic intermediates—most prominently leucine-derived AcCoA—as key regulators that couple nutrient flux to mTORC1 via EP300 (p300)-mediated acetylation of Raptor. Chronic disruption of this regulatory axis leads to persistent mTORC1 hyperactivity, autophagy failure, and progressive accumulation of proteotoxic species, which contribute across major neurodegenerative diseases.
This review synthesizes current understanding of neuronal mTORC1 control, emphasizes the emerging AcCoA–acetylation axis, examines disease-specific implications, and highlights therapeutic opportunities that act upstream of mTORC1 to restore neuronal clearance mechanisms.